Research

Articles

Dr. Marion McNabb has been conducting surveys related to medical cannabis for about five years and her most recent endeavor is to gauge the knowledge, interest, and understanding of medical cannabis in healthcare professionals. In this interview, she discusses her latest study as well as her background and key insights into the medical cannabis industry.

Research Abounds: How Dr. Marion McNabb is Looking to Take the Medical Cannabis Industry to the Next Level

A systematic literature review to identify and compare analytical methods used for the determination of cannabinoids in different matrices using LC-based systems.

Analytical Techniques Used for Analysis of Cannabinoids

NFL-NFLPA Joint Pain Management Committee (PMC) plans to award up to $1 million in grants to CBD and cannabis researchers.

NFL Defies Prohibition to Fund Cannabis Research

The Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth  have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.

Healthcare Provider-Focused Medical Cannabis Research Study Launched by Cannabis Center of Excellence, Medicinal Genomics, and UMass Dartmouth

Josh Crossney is the columnist and editor of “Cannabis Crossroads” and a contributing editor to 

 magazine. Crossney is also the president and CEO of Cannabis Science Conference. Direct correspondence to:


Rebecca Jackson discusses a new program at the Maryland Medical Cannabis Commission (MMCC) and what they hope to achieve with it.

Calling All Maryland Researchers:  MMCC Seeks Candidates to Apply for Academic Cannabis Research Licenses

As globalization of demand for cannabis and its derivative products increase, new technology and artificial intelligence solutions can greatly boost the output of production and processing.

New Age Artificial Intelligence for Cannabis Production?

There’s more hemp out there than the industry knows what to do with.

There’s a Surplus of Hemp in the Market: What Happens in 2021?

Professor Edvinas Orentas clears the air surrounding the stigma of synthetic cannabinoids.

The Power of  Synthetic Cannabinoids  and Why Big Pharma Prefers Them

Dr. Walter Wilson discusses NIST's focus on developing cannabis reference materials and a quality assurance program (CannaQAP).

Is This Cannabis or Hemp—NIST Helps Cannabis Laboratories Achieve High-Quality Measurements

What are the environmental implications of energy consumption for outdoor, indoor, and greenhouse cultivation?